Deutsche Bank Ag\ 908 Devices Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in 908 Devices Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 99,239 shares of MASS stock, worth $222,295. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,239

Previous 7,880 1159.38%

Holding current value

$222,295

Previous $27,000 707.41%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.88 - $3.91 $171,754 - $357,213	91,359 Added 1159.38%	99,239 $218,000
Q2 2024 Aug 14, 2024	SELL	$5.0 - $7.24 $10,155 - $14,704	-2,031 Reduced 20.49%	7,880 $40,000
Q1 2024 May 15, 2024	SELL	$6.55 - $9.92 $2,999 - $4,543	-458 Reduced 4.42%	9,911 $74,000
Q2 2023 Aug 14, 2023	SELL	$5.78 - $10.02 $24,385 - $42,274	-4,219 Reduced 28.92%	10,369 $71,000
Q1 2023 May 15, 2023	BUY	$6.61 - $10.66 $35,237 - $56,828	5,331 Added 57.59%	14,588 $125,000
Q4 2022 Feb 13, 2023	BUY	$7.0 - $17.96 $1,029 - $2,640	147 Added 1.61%	9,257 $70,000
Q3 2022 Nov 14, 2022	SELL	$15.18 - $24.99 $22,102 - $36,385	-1,456 Reduced 13.78%	9,110 $150,000
Q2 2022 Aug 11, 2022	SELL	$13.3 - $20.74 $5,572 - $8,690	-419 Reduced 3.81%	10,566 $217,000
Q1 2022 May 13, 2022	SELL	$13.18 - $26.28 $9,252 - $18,448	-702 Reduced 6.01%	10,985 $209,000
Q4 2021 Feb 11, 2022	SELL	$23.17 - $38.77 $30,121 - $50,401	-1,300 Reduced 10.01%	11,687 $302,000
Q3 2021 Nov 04, 2021	BUY	$29.99 - $39.13 $246,937 - $322,196	8,234 Added 173.24%	12,987 $422,000
Q2 2021 Aug 11, 2021	SELL	$36.7 - $55.11 $51,159 - $76,823	-1,394 Reduced 22.68%	4,753 $184,000
Q1 2021 May 13, 2021	BUY	$39.94 - $75.0 $245,511 - $461,025	6,147 New	6,147 $298,000

Others Institutions Holding MASS

# of Institutions

Shares Held

16.7M

Call Options Held

500

Put Options Held

29.9K

View Full List

About 908 Devices Inc.

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $70.8M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

More about MASS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account